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A B S T R A C T
Psychiatric illnesses are complex and polygenic. They are associated with widespread alterations in the brain,
which are partly influenced by genetic factors. There have been some attempts to relate polygenic risk scores
(PRS) – a measure of the overall genetic risk an individual carries for a disorder – to brain structure using
univariate methods. However, PRS are likely associated with distributed and covarying effects across the brain.
We therefore used multivariate machine learning in this proof-of-principle study to investigate associations
between brain structure and PRS for four psychiatric disorders; attention deficit-hyperactivity disorder (ADHD),
autism, bipolar disorder and schizophrenia. The sample included 213 individuals comprising patients with de-
pression (69), bipolar disorder (33), and healthy controls (111). The five psychiatric PRSs were calculated based
on summary data from the Psychiatric Genomics Consortium. T1-weighted magnetic resonance images were
obtained and voxel-based morphometry was implemented in SPM12. Multivariate relevance vector regression
was implemented in the Pattern Recognition for Neuroimaging Toolbox (PRoNTo). Across the whole sample, a
multivariate pattern of grey matter significantly predicted the PRS for autism (r=0.20, pFDR= 0.03;
MSE=4.20×10−5, pFDR=0.02). For the schizophrenia PRS, the MSE was significant (MSE=1.30×10−5,
pFDR= 0.02) although the correlation was not (r=0.15, pFDR= 0.06). These results lend support to the hy-
pothesis that polygenic liability for autism and schizophrenia is associated with widespread changes in grey
matter concentrations. These associations were seen in individuals not affected by these disorders, indicating
that this is not driven by the expression of the disease, but by the genetic risk captured by the PRSs.
1. Introduction
Common psychiatric illnesses have complex etiologies and are
polygenic (Lee et al., 2013; Wray et al., 2014). Autism, bipolar disorder
and schizophrenia consistently show high heritability estimates, both
from twin studies (up to 90%) and molecular genetic studies
(Geschwind and Flint, 2015; Sullivan et al., 2012). Attention-deficit
hyperactivity disorder (ADHD) is however known to have relatively
fewer genetic influences with environmental risk factors playing a
greater role in disease liability, and heritability estimates for ADHD in
adults ranges from 40% to 70% (Brikell et al., 2015; Burmeister et al.,
2008; Franke et al., 2011).
Genetic variants associated with an increased risk of developing a
range of psychiatric illnesses have started to be identified (Cross-
Disorder Group of the Psychiatric Genomics Consortium, 2013;
Marshall et al., 2016; Sklar et al., 2011; Stefansson et al., 2008; Stone
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et al., 2008); most notably for schizophrenia where over 100 common
genetic variants have been significantly detected (Ripke et al., 2014).
Progress has also been made for bipolar disorder, where a handful of
common variants have been identified (Chen et al., 2013; Sklar et al.,
2011). However, for other disorders such as ADHD and autism, very
few common genetic risk variants have been reliably detected (Warrier
et al., 2015). Furthermore, it is still largely unknown how genetic risk
variants lead to the development of psychiatric symptoms; an important
goal of psychiatric genetic research is therefore to clarify the mechan-
isms of these variants (Bogdan et al., 2017; Carter et al., 2017; Glahn
et al., 2014; Hall and Smoller, 2010; Harrison, 2015).
The polygenic risk score (PRS) is an estimate of the combined effect
of a large number of common genetic variants (single nucleotide
polymorphisms, SNPs) associated with a trait, each with a very subtle
individual effect (Chatterjee et al., 2016; Dima and Breen, 2015; Purcell
et al., 2009; Wray et al., 2014). PRSs for psychiatric illnesses differ
between patients and controls, thus providing a useful tool to measure
genetic liability to psychiatric disorders (Bramon et al., 2014; Derks
et al., 2012; Power et al., 2015; Purcell et al., 2009; Ranlund et al.,
2017; Vassos et al., 2017), including non-affected individuals. Thus,
associations with PRS are predicted to be independent of current dis-
ease state and can be seen in healthy participants who may not have
developed a disorder.
We chose to investigate associations between PRSs for four major
psychiatric disorders and brain structure. A wide range of both cortical
and subcortical brain structural alterations have been observed in pa-
tients with psychiatric illnesses, including in ADHD (Frodl and
Skokauskas, 2012; Hoogman et al., 2017; Nakao et al., 2011; Valera
et al., 2007), autism (Cauda et al., 2011; Deramus and Kana, 2015;
Duerden et al., 2012; Nickl-Jockschat et al., 2012), bipolar disorder
(Arnone et al., 2009; Hibar et al., 2016; Selvaraj et al., 2012; Vita et al.,
2009; Wise et al., 2016), and schizophrenia (Bora et al., 2011;
Palaniyappan et al., 2015; Radua et al., 2012; Steen et al., 2006; van
Erp et al., 2015). Furthermore, brain structure is influenced by genetic
factors, with high heritability estimates for measures including grey
matter volumes (Batouli et al., 2014; Glahn et al., 2007; Jansen et al.,
2015; Peper et al., 2007), and studies have linked genetic risk for
psychiatric disorders to variations in brain structure (Doyle et al., 2015;
Lee et al., 2016; McIntosh et al., 2006; Turner et al., 2012; Van Haren
et al., 2012).
Amongst the psychiatric illnesses, the schizophrenia PRS has been
most widely investigated to date; and although some studies have found
associations with brain structure (Neilson et al., 2016; Terwisscha van
Scheltinga et al., 2013), others have found no significant associations
(Papiol et al., 2014; Van der Auwera et al., 2015; Voineskos et al.,
2016). Whalley and colleagues (2013) also investigated the PRS for
bipolar disorder but found no significant associations with fractional
anisotropy in white matter tracts. Lastly, Reus et al. (2017) found no
associations between PRS for schizophrenia, bipolar disorder or de-
pression in a range of brain structural measures including total grey
matter, white matter and subcortical volumes.
These studies all used a univariate approach, where brain voxels or
regions-of-interest are tested individually against the PRS. However, we
know that the PRS is an estimate of the overall genetic risk an in-
dividual carries for a disorder. It is plausible to consider this risk acting
throughout development and thus the influence on brain structure may
best be captured by considering co-varied and distributed effects across
the whole brain, rather than large, localized effects. Hence, a multi-
variate machine learning method – that considers the pattern of inter-
relationships between measurements (e.g. grey matter volumes across
the brain) – might be a more powerful method to detect subtle and
spatially distributed patterns of alterations. The aim is not to localize
effects in the brain or to identify specific regions that are predictive.
PRSs were used recently in a multivariate machine learning setting to
differentiate schizophrenia and/or bipolar disorder patients from
healthy controls by combining the PRS with brain and cognitive vari-
ables (Doan et al., 2017). However, adding the PRS did not improve the
classifying performance of the algorithm, implying that the PRS's pre-
dictive value is captured by brain variables (Doan et al., 2017).
In this study, we investigated the associations between brain
structure and polygenic risk scores for four psychiatric disorders;
ADHD, autism, bipolar disorder, and schizophrenia. We first present a
univariate regression, followed by a multivariate analysis investigating
whether the pattern of grey matter densities across the brain can predict
an individual's PRS. We hypothesised that a multivariate approach
would be more sensitive to detect associations between brain structure
and PRSs compared to a univariate method, and that predictions would
be stronger for highly heritable disorders with larger genetic influences
like autism, schizophrenia and bipolar disorder, compared to ADHD
that is known to be less heritable.
2. Methods and materials
2.1. Participants
The sample included 213 participants from two studies; 69 patients
with major depressive disorder and 70 healthy controls from the
BRCDECC study (Cole et al., 2012, 2013; Costafreda et al., 2013), and
33 patients with bipolar disorder and 41 healthy controls from the
VIBES study (Dima et al., 2016a, b; Frangou et al., 2017). All partici-
pants were unrelated and of white European ancestry. Table 1 includes
a summary of demographic and clinical information for the
Table 1
Participants' characteristics.
Whole sample
N=213
Depression BRCDECC study
N=139
Bipolar VIBES study
N=74
Patients with depression
N=69
Healthy controls
N=70
Patients with bipolar disorder
N=33
Healthy controls
N=41
Age
(mean years± SD; range)
45.91 ± 11.48
18–68
48.77 ± 8.29
29–68
51.13 ± 7.64
26–66
43.36 ± 11.34
21–63
44.22 ± 13.05
18–63
Sex
(% female)
57.75% 71.01% 55.71% 48.48% 46.34%
Full IQ
(WAIS-R)a
118.71 ± 13.37 117.34 ± 11.32 120.83 ± 8.91 118.23 ± 19.53 117.70 ± 17.13
Age of onsetb (years) – 20.87 ± 9.28 – 23.79 ± 7.46 –
Illness durationb (years) – 30.59 ± 12.37 – 19.88 ± 10.66 –
HDRS – – – 2.47 ± 2.83 0.25 ± 0.63
YMRS – – – 1.07 ± 2.62 0.18 ± 0.50
BDI – 15.16 ± 11.30 1.70 ± 1.63 – –
Continuous data shown as mean ± standard deviations (SD). WAIS-R=Wechsler Adult Intelligence Scale – Revised version; HDRS=Hamilton Depression Rating
Scale; YMRS=Young Mania Rating Scale; BDI=Beck Depression Inventory. a Data available for 98% of sample. b Data available for 81% of patients.
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participants.
Participants from the BRCDECC study included patients with de-
pression who had experienced two or more depressive episodes of at
least moderate severity and met DSM-IV diagnostic criteria for re-
current major depressive disorder (APA, 1994), assessed using the
Schedules for Clinical Assessment in Neuropsychiatry (Wing et al.,
1990). The healthy controls were interviewed to ensure they had never
experienced a depressive episode. Exclusion criteria included a diag-
nosis of a neurological disorder, head injury leading to loss of con-
sciousness, or conditions known to affect brain structure or function
(including alcohol or substance misuse), ascertained during clinical
interview. Potential participants were also excluded if they or a first-
degree relative had ever fulfilled criteria for mania, hypomania, schi-
zophrenia or mood-incongruent psychosis. Current depressive symp-
toms were measured using the Beck Depression Inventory (BDI) (Beck
et al., 1961).
Participants from the VIBES study included euthymic patients with
bipolar disorder and healthy individuals. The diagnostic status of all
participants was assessed using the Structured Clinical Interview for
DSM-IV for Axis I diagnoses (First et al., 2002a; First et al., 2002b).
Patients fulfilled criteria for bipolar disorder type I according to the
Diagnostic and Statistical Manual of Mental Disorders, 4th edition, re-
vised (DSM-IV) (APA, 1994). Healthy controls were selected based on
the absence of family history and personal lifetime history of psychia-
tric disorders. To ensure that patients were in remission, their psy-
chopathology was assessed weekly over a period of 1month prior to
testing and at each assessment they scored below 7 in the Hamilton
Depression Rating Scale (HDRS) (Hamilton, 1960) and the Young
Mania Rating Scale (YMRS) (Young et al., 1978). Patients were also
required to have remained on the same type and dose of medication for
a minimum of 6months. All participants were free of any medical co-
morbidity and had no lifetime history of substance dependence or
substance abuse in the six months leading to their brain scan.
The BRCDECC study was approved by the Bexley and Greenwich
Research Ethics Committee, and the VIBES study was approved by the
Ethics Committee of the Institute of Psychiatry and the South London
and Maudsley National Health Service Trust. Written informed consent
was obtained from all participants.
2.2. DNA extraction and genotyping
DNA was obtained from all participants using buccal swabs and/or
blood. Participants from the VIBES study were genotyped on the Psych
Chip (Illumina Infinium PsychArray-24) and participants from the
BRCDECC study were genotyped using the Illumina HumanHap610-
Quad BeadChip. SNP positions were lifted over from hg18 to hg19 build
using the UCSC LiftOver tool. The data were imputed using the
Michigan Imputation Server (Das et al., 2016) (https://
imputationserver.sph.umich.edu/index.html) with 1000 Genomes as
reference set utilizing SHAPEIT and Minimac software. Data quality
was controlled in PLINK v1.07 (Purcell et al., 2007). In short, SNPs
were excluded when missingness> 1%, minor allele frequency
(MAF)<1%, or Hardy-Weinberg equilibrium (HWE) p < .00001, and
participants were excluded when missingness> 1%. Sex and related-
ness checks were carried out, in addition to principal component ana-
lyses, to confirm self-reported ethnicities (Patterson et al., 2006).
2.3. Polygenic risk scores
Genome-wide polygenic risk scores (PRSs) for ADHD, Autism
Spectrum Disorder, Bipolar Disorder, and Schizophrenia were gener-
ated with PRSice software (http://prsice.info/) (Euesden et al., 2014),
using the most recent Psychiatric Genomics Consortium genome-wide
association analyses within the cross disorder study (Cross-Disorder
Group of the Psychiatric Genomics Consortium, 2013) and schizo-
phrenia GWAS (Ripke et al., 2014), available from the PGC website
(www.med.unc.edu/pgc/results-and-downloads). The SNPs used were
P-value-informed clumping in PLINK with a cut-off of r2= 0.25 within
a 200-kb window, and excluding the MHC region of the genome be-
cause of its complex linkage disequilibrium structure. For each parti-
cipant, PRSs were generated using SNPs with a p-value threshold
of< 0.1 in the panel of SNPs from the Psychiatric Genomics Con-
sortium (see Table S1 in the supplement for discovery sample sizes from
the Psychiatric Genomics Consortium, and the number of SNPs included
for each PRS). None of the individuals in our study were included in the
GWAS data used to identify the SNPs. Since we calculated 5 psychiatric
PRS scores, we decided to use the P-threshold of< 0.1 as it has been
shown that progressive P-thresholds at liberal thresholds explain more
variance in the clinical phenotype (Ruderfer et al., 2014).
2.4. MRI data acquisition
For participants from the BRCDECC study, T1-weighted structural
images were acquired using a 1.5-Tesla General Electric Signa MR
Imaging system (General Electric, Milwaukee, WI, USA), in the sagittal
plane (magnetization-prepared rapid gradient-echo sequence; repeti-
tion time (TR)=8.592ms, echo time (TE)= 3.8ms, inversion time
(TI)= 1000ms, slice thickness= 1.2mm, voxel dimen-
sions= 0.939×0.937×1.2mm, matrix size 192×192, field of
view=240, flip angle= 8°) (Cole et al., 2013).
For participants from the VIBES study, T1-weighted structural
images were acquired using a 1.5-Tesla GE Neuro-optimised Signa MR
system (General Electric, Milwaukee, WI, USA), in the axial plane (in-
version recovery prepared, spoiled gradient-echo sequence;
TR=18ms, TE=5.1ms, TI= 450ms, slice thickness= 1.5mm, voxel
dimensions= 0.9375×0.9375× 1.5mm, matrix size 256×192, field
of view=240, flip angle= 20°, number of excitations= 1) (Dima
et al., 2016a; Frangou et al., 2017).
2.5. MRI data processing
All MRI images were pre-processed using a standard voxel-based
morphometry (VBM) pipeline (Ashburner and Friston, 2000), im-
plemented in Statistical Parametric Mapping (SPM12) (www.fil.ion.ucl.
ac.uk/spm/software/spm12/), running on Matlab 2016 (Math Works,
USA).
The origins of all images were manually set to the anterior com-
missure. The images were then segmented into grey matter, white
matter, and cerebrospinal fluid using unified segmentation. The
Diffeomorphic Anatomical Registration using Exponential Lie algebra
(DARTEL) algorithm (Ashburner, 2007) was applied to the segmented
brain tissues to generate a study-specific template, and images were
normalised to the template using non-linear warping.
Normalization to standard space, including smoothing using an
8mm full-width-half-maximum Gaussian kernel, was done in two ways;
including a “modulation” step or not. Modulation scales the grey matter
probability values after spatial normalization to ensure that the total
amount of grey matter in each voxel is conserved after warping
(Mechelli et al., 2005). This is recommended for univariate voxel-wise
analysis of grey matter volumes. However, for a multivariate analysis,
when the relationship between grey matter intensities across voxels is
modelled, it might be better to preserve concentrations of grey matter
(i.e. not to modulate images) because modulation could alter the inter-
relationship between voxel values. Hence, we use modulated images for
the univariate analysis, and non-modulated images for the multivariate
analysis. Total intracranial volume (including grey matter, white matter
and cerebrospinal fluid) was calculated for all individuals for inclusion
in the analyses as covariates.
To explore potential differences in grey matter volume between
patients and controls, we used a standard univariate voxel-based mor-
phometry (VBM) analysis in SPM12 (Ashburner and Friston, 2000), in
the two studies separately. The input features were the smoothed,
S. Ranlund et al. NeuroImage: Clinical 20 (2018) 1026–1036
1028
modulated, normalised grey matter images. Covariates (included as
nuisance regressors) were age, sex, and intracranial volume. An explicit
grey matter mask was applied. Two-sample t-tests were conducted (for
the two studies separately). The significance threshold was set using
family-wise error (FWE) correction (p < .05), and we report clusters
larger than k=20.
2.6. Univariate regression analysis
We first investigated the relationship between grey matter volume
and polygenic risk scores (for ADHD, autism, bipolar disorder, and
schizophrenia) in our sample of 213 individuals, using a standard,
univariate voxel-based morphometry (VBM) analysis in SPM12
(Ashburner and Friston, 2000).
The input features for the univariate multiple regression were the
smoothed, modulated, normalised grey matter images. Covariates (in-
cluded as nuisance regressors) were age, sex, intracranial volume,
status (patient, control), and study (BRCDECC, VIBES). An explicit grey
matter mask was applied. We looked for regions with either a linear
increase or decrease in grey matter volume associated with higher PRS
(i.e. both positive and negative associations). We report clusters re-
maining significant after family-wise error (FWE) correction (p < .05,
with a cluster forming threshold of p < .001), and regions surviving
FWE correction at the voxel level (p < .05).
2.7. Multivariate regression analysis
We then tested whether a multivariate pattern of grey matter pre-
dicts polygenic risk scores for the five psychiatric disorders (ADHD,
autism, bipolar disorder, and schizophrenia) in the whole sample in-
cluding 213 individuals. This was done using multivariate Relevance
Vector Regression (RVR) (Tipping, 2001) implemented in the Pattern
Recognition for Neuroimaging Toolbox (PRoNTo; Schrouff et al., 2013)
(www.mlnl.cs.ucl.ac.uk/pronto) running on Matlab 2016.
RVR is a probabilistic kernel-based pattern recognition method
using Bayesian inference to obtain sparse regression models, and allows
the extraction of patterns within a high-dimensional feature space (such
as voxel-based intensities representing local grey matter concentration).
This method has been described previously (Araque Caballero et al.,
2016; Gong et al., 2014; Moradi et al., 2017; Tognin et al., 2014).
The input features for the multivariate pattern analyses were the
smoothed, normalised grey matter images. Covariates – including age,
sex, group status (patient, control), study (BRCDECC, VIBES), and in-
tracranial volume – were regressed out from the training data, and the
same transformation was applied to the test data within the cross-va-
lidation framework. The RVR was trained using a leave-one-subject-out
cross-validation. This is a frequently used validation method, involving
leaving one participant out for test and train the model on N-1 parti-
cipants, and doing so N times so that each participant is left out once.
We also repeated our analyses leaving 10% of the sample out (i.e. a ten-
fold cross-validation). Because our sample size was not divisible by ten,
9 folds contained 21 individuals and 1-fold contained 24 individuals.
These additional results are presented in the supplement (Table S6).
We report the Pearson correlation coefficient and the Mean Squared
Error (MSE; normalised to the range of the predicted variable) between
the actual and predicted PRS. These reflect how well a multivariate
pattern of grey matter predicts an individual's PRS; a correlation of 1
would indicate that the predicted PRS is identical to the actual PRS, and
an MSE of 0 would mean that there is no error in this prediction. Note
that in a multivariate analysis results do not imply whether there is a
positive or negative association between grey matter and PRS, instead it
is the pattern of grey matter across the brain – which could include both
increases and decreases – that predicts the PRS.
The significance of both the correlation coefficient and the MSE
were estimated using a permutation test whereby the target data were
randomised and the model re-run 1000 times (with the lowest p-value
attainable being 1/1000=0.001). We also present regions (from the
Automatic Anatomical Labelling (AAL) atlas), and their weights, that
contribute the most to estimations of PRSs. Importantly, however, in a
multivariate analysis all voxels contribute to the predictions and we
present the regional contributions for visualization purposes only. As
described in Schrouff et al. (2013; pg. 232), “this is because it is the
combination of all weights that defines the model, and the weights at
each voxel are dependent of one another and no direct lozalization or
voxel-wise statistical test assuming independence can be performed on
them”.
Since we are conducting four multivariate analyses (for the five
different polygenic risk scores), we correct p-values for multiple testing
using false discovery rates (FDR) implemented in Matlab using the
Benjamini and Hochberg (1995) procedure. We decided to use the FDR
correction by Benjamini and Hochberg since the four PRS scores are not
independent.
As secondary analyses, to investigate whether associations are
driven by subgroups of participants, we repeated the multivariate re-
gression models including only patients (N=102), only patients with
major depression (N=69) or bipolar disorder (N=33), as well as in-
cluding only healthy controls (N=111).
3. Results
Participants' characteristics are presented in Table 1.
3.1. Polygenic risk scores
Patients with depression, bipolar disorder and healthy controls did
not differ in mean ADHD, autism, or schizophrenia PRS. However, the
three groups differed in the bipolar disorder PRS (F(2,210)= 12.05,
p=1.11× 10−5), with patients with bipolar disorder having the
highest risk, followed by patients with major depression, and lastly
controls. See Table 2. Raw scores across the three groups are presented
in the supplement (Table S2, Fig. S1).
Pairwise correlations showed that the schizophrenia PRS was sig-
nificantly associated with scores for ADHD (r=0.20, pFDR= 0.01) and
bipolar disorder (r=0.60, pFDR= 2.2×10−15), and the ADHD and
bipolar risk scores were also correlated (r=0.23, pFDR=0.0007). The
other pairwise correlations were not significant. See the supplement for
full results (Table S3, Fig. S2).
3.2. Univariate analysis results
We explored differences in grey matter volume between patients
and controls using VBM analysis separately in the depression BRCDECC
and the bipolar VIBES study. No significant results were found.
We investigated the association between grey matter volumes and
PRSs using univariate multiple regression, in the whole sample of 213
individuals. No results remained significant after family-wise error
(FWE) correction for ADHD, autism, or bipolar disorder, PRS.
For the schizophrenia PRS, no cluster remained significant after
FWE cluster correction, however one region (including 24 voxels, peak
MNI coordinates: x= 46, y=−78, z= 28mm, right inferior occipital
gyrus) remained significant at the voxel-level, with a FWE-corrected
peak-level p-value of 0.005 (z-value= 4.99); increased PRS was asso-
ciated with increased grey matter volumes.
Un-thresholded t-maps for associations with the four PRSs are
shown in the supplement (Fig. S3).
3.3. Multivariate regression results
We then investigated the association between brain structure and
PRSs using multivariate relevance vector regression with the leave-one-
subject-out cross-validation. In the whole sample of patients and
healthy controls, a multivariate pattern of grey matter intensity
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significantly predicted the PRS for autism (r=0.20, pFDR= 0.03,
MSE=4.20×10−5, pFDR= 0.02). Associations with the schizophrenia
PRS were significant when looking at the mean squared error
(MSE=1.30× 10−5, pFDR=0.02), and the correlation (r=0.15,
punc= 0.032); however the correlation did not survive FDR correction
(pFDR= 0.06). The PRSs for ADHD and bipolar disorder were not sig-
nificantly associated with grey matter across the whole sample. These
results are presented in Table 3 and Figs. 1A and 2A.
Importantly, the results were stable across folds as illustrated by the
proximity of the expected ranking to the actual rankings for the regions
with the five highest weights (see Table S4 and Fig. S4 in the supple-
ment). The expected ranking indicates how consistent the ranking is
across cross-validation folds; if the expected ranking is close to the
actual ranking of a region (by weight) then the result is considered
stable across the folds. For the autism PRS the left inferior parietal gyrus
contributed 1.60% to the regression and the expected ranking was 1.00.
For the left angular gyrus these values were 1.43% and 2.12, the left
occipital lobe 1.38% and 3.15, the left cuneus 1.32%, 4.18 and left
precentral gyrus 1.30%, 5.10. For the schizophrenia PRS the right an-
gular gyrus contributed 1.53% to the regression and the expected
ranking was 1.11. For the right superior occipital lobe these values were
1.48% and 2.40, the cerebellar vermis 1.05% and 3.09, left middle
occipital lobe 1.34%, 4.37 and left superior occipital lobe 1.33%, 4.83.
While these weights are in keeping with the proportion of brain volume
for each region, they are low, indicating that the pattern of associations
is widespread across the brain; this is seen in Figs. 1B and 2B where the
weight maps of contribution of voxels across the whole brain to pre-
diction of PRSs are shown.
As secondary analyses, to investigate whether associations are
driven by subgroups of participants, we repeated the multivariate re-
gression models including only patients (N=102), only patients with
major depression (N=69) or bipolar disorder (N=33), as well as in-
cluding only healthy controls (N=111). None of these analyses were
significant and these results are presented in the supplement (Table S5).
We also repeated the analysis using a randomly selected subsample of
100 individuals (comprising both patients and controls), in order to
investigate whether this lack of prediction above was likely due to the
reduced sample size. This analysis was also non-significant (Table S7).
We also re-ran our analyses using a 10-fold cross-validation. This
resulted in findings very similar to the original analyses, and are pre-
sented in Table S6 in the supplement.
4. Discussion
We aimed to investigate associations between polygenic risk scores
(PRSs) for four psychiatric disorders (ADHD, autism, bipolar disorder
and schizophrenia) and brain volumes. Results showed that the PRS for
autism and schizophrenia were associated with a multivariate pattern
of grey matter concentrations in this sample of healthy controls and
psychiatric patients. PRSs for ADHD and bipolar disorder, however,
could not be predicted by brain structure in this study. These findings
lend support to the hypothesis that the polygenic liability for autism
and potentially schizophrenia is associated with changes in grey matter
concentrations across the brain.
Both autism and schizophrenia are complex neurodevelopmental
disorders that are highly polygenic. Our findings show that the PRSs for
these two disorders are not correlated, indicating that although both
reflect commonly occurring genetic risk factors, these loci are not
shared between these disorders. This is consistent with previous studies
finding low genetic correlations between these two disorders in terms of
common genetic variation (Cross-Disorder Group of the Psychiatric
Genomics Consortium, 2013; Lee et al., 2013). For autism, although
many rare variants such as de novo mutations and copy number var-
iants have been identified (Buxbaum, 2009; Ronemus et al., 2014;
Sanders et al., 2015), no single nucleotide polymorphism (SNP) has yet
been significantly detected (Warrier et al., 2015). That we find a sig-
nificant association with brain structure is in line with arguments that
the PRS captures causal variation not yet significantly identified in
genome-wide association studies (Wray et al., 2014).
For schizophrenia, over 100 common SNPs have been detected
Table 2
Polygenic risk scores (PRS) for the four disorders. Shown are tests for overall group differences (F tests), and the differences from controls in standardised z scores
(to controls' means and standard deviations, SD) for patients with depression and patients with bipolar disorder (± SD).
Polygenic Risk Score (PRS) F test, p-value Patients with Major Depression
(vs. HC)
Patients with Bipolar Disorder
(vs. HC)
p-values for two-sample t-tests⁎
ADHD PRS F(2,210)=0.18, p=.83 0.09 ± 0.92 0.09 ± 1.13 NS
Autism PRS F(2,210)=1.68, p=.19 0.04 ± 1.05 0.36 ± 0.88 NS
Bipolar Disorder PRS F(2,210)=12.05, p= 1.1× 10−5 0.40 ± 0.46 0.77 ± 0.95 HC vs MDD patients p=.002
HC vs BPD patients
p=8.6×10−6
MDD vs BPD patients p= .043
Schizophrenia PRS F(2,210)=0.77, p=.47 0.12 ± 0.42 0.06 ±0.59 NS
*Comparison between groups (two-sample t-tests, uncorrected for multiple testing), for polygenic risk scores with significant overall group differences (i.e. Bipolar
Disorder PRS).
NS=Not significant
ADHD=Attention Deficit Hyperactivity Disorder; BPD=Bipolar Disorder; HC=Healthy Controls; MDD=Major Depressive disorder.
Note: The control group includes controls from both samples (N=111)
Table 3
Multivariate pattern recognition results. Correlations (r) between the actual and predicted polygenic risk scores (PRS) – from grey matter volumes – and
(normalised) mean squared errors (MSE) in the whole sample (N=213).
ADHD PRS Autism PRS Bipolar Disorder PRS Schizophrenia PRS
r=−0.11 r=0.20 r=−0.01 r=0.15
punc= 0.821
pFDR= 0.821
punc= 0.008
pFDR=0.032
punc= 0.518
pFDR= 0.690
punc= 0.032
pFDR=0.064
MSE=6.19× 10−5 MSE=4.20× 10−5 MSE=5.18× 10−5 MSE=1.30× 10−5
punc= 0.950
pFDR= 0.950
punc= 0.005
pFDR=0.020
punc= 0.266
pFDR= 0.354
punc= 0.012
pFDR=0.024
ADHD=Attention Deficit Hyperactivity Disorder; punc= uncorrected p-value; pFDR= False Discovery Rate corrected p-value.
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(Ripke et al., 2014). The discovery sample used to calculate the PRS for
schizophrenia is substantially larger than for any of the other disorders
investigated here, making the schizophrenia PRS relatively powerful
(Purcell et al., 2009; Ripke et al., 2014). We know that larger discovery
sample sizes will lead to more true positive variants being included in
the risk score, and hence the score being a more sensitive marker of
genetic risk (Dudbridge, 2013; Wray et al., 2014). Once discovery
samples sizes increase for the other disorders and more significant loci
are identified, we might expect to see more significant associations in
the kind of analyses conducted in this study, if there is a true link be-
tween psychiatric genetic risk and brain structure.
Given the lack of SNPs associated with autism and the smaller dis-
covery sample size compared to schizophrenia for the PRS calculation,
it is interesting that we find associations between brain structure and
the autism PRS. If replicated, this might be due to the early develop-
ment of autism and its association with severe lifelong neurodevelop-
mental symptoms (Baxter et al., 2015). Hence, associations between
genetic risk for autism and brain structure might be relatively large
compared to disorders that emerge later in life. Furthermore, Lee et al.
(2013) found that the proportion of variance explained by SNPs located
in genes that are expressed in the central nervous system is relatively
high for autism compared to other psychiatric disorders investigated
here. It could thus be suggested that genes associated with autism in-
fluence brain structure to a relatively large degree and is more wide-
spread than first suspected.
We see these associations between PRS for autism and schizo-
phrenia and grey matter in a sample not including patients affected by
these disorders, indicating that this is not driven by the expression of
the disease, but by the genetic risk captured by the PRSs. Furthermore,
there was no evidence in our sample that the associations between PRS
and grey matter patterns were moderated by diagnostic status (MDD or
bipolar), and this indicates that disease status or use of medication is
not driving the associations. However, we acknowledge that MDD and
bipolar disorder patients were a subset of the overall sample.
We found no evidence for associations between brain grey matter
and genetic risk for bipolar disorder, or ADHD. When it comes to
ADHD, since this disorder has been found to be less heritable with
larger environmental influences (Brikell et al., 2015; 2015; Franke
et al., 2011;), the lack of associations here are perhaps unsurprising.
However, given the large genetic overlap between bipolar disorder and
schizophrenia, seen both in the correlation between these scores in this
study and in the literature (Craddock et al., 2005; Cross-Disorder Group
of the Psychiatric Genomics Consortium, 2013; Lee et al., 2013;
Lichtenstein et al., 2009), it is somewhat surprising that we observed a
trend level association for schizophrenia but not for bipolar disorder.
This might be due to the significantly larger discovery sample size used
to calculate the risk score for schizophrenia. Furthermore, compared to
autism, bipolar disorder develops later in life, which could explain
these lack of findings; maybe genetic risk associated with these dis-
orders do not have as strong an influence on structural neurodevelop-
ment as that for autism.
In a multivariate analysis, all voxels contribute to predictions and it
is not possible to single out whether any region is predictive in isola-
tion. In our study, maybe the most important conclusion from the
Fig. 1. Results for the autism polygenic risk score (PRS). A) Correlations between actual autism PRS and the PRS predicted from the grey matter volume maps.
pFDR= False Discover Rate corrected p-values. B)Weight maps of contribution of voxels across the whole brain for the predicted autism PRS shown in A (in the whole
sample, N=213).
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weight maps is that the pattern of grey matter predicting PRS is
widespread across the whole brain; large regions identified (voxel size
~5000) and very small weights attributed even to the top regions with
weights of no>1.6%. This widespread multivariate pattern justifies
the use of multivariate machine learning models, since it will likely be
more difficult to identify significantly associated regions using a uni-
variate method (Cohen et al., 2017; Woo et al., 2017). This is evident in
our findings, especially for the autism PRS where we find a multivariate
association but no significant univariate results. Nevertheless, an im-
portant goal of future work is to use multivariate methods that might be
able to provide more insight into what brain regions are most important
for predictions, such as sparse network-based methods or elastic net
classifiers. Another feature of the multivariate analysis is that the
output is a weight map which does not speak to whether these areas
have increased or decreased grey matter volumes in relation to PRS
scores. The univariate analysis for the PRS for schizophrenia revealed
only one significant positive correlation between schizophrenia PRS
and the right inferior occipital gyrus, contributing to the argument of
using multivariate machine learning methods.
We consider this to be a proof-of-principle study, and while our
sample size is relatively large for imaging research, it is small when
compared to genetic studies. Furthermore, although we use cross-vali-
dation (including the leave-out-out method in the main paper, as well
as a ten-fold cross-validation in the Supplement), these findings need
replication in large independent samples to be confirmed, ideally in a
large sample of healthy individuals not constrained by disease status. A
limitation of the PRS is that because it is an estimate of the combined
genetic risk carried by an individual, it does not tell us what specific
variants are most important for the association observed. Therefore,
future research should investigate whether a subset of common genetic
variants (e.g. on a functional pathway) are more strongly influencing
grey matter structure. These findings identify brain correlates of PRS,
but do not inform on the functional role of these systems in conferring
risk, which is an important question as more data becomes available,
including developmental and longitudinal data. Further limitations of
this study include the use of MRI data from two different scanners,
which might have influenced results (although this was included as a
covariate in all analyses), and that we did not have both neuroimaging
and genetic data available from patients with autism, ADHD, or schi-
zophrenia. Lastly, the method applied in this paper does not allow to
test for PRS by diagnosis interaction.
In summary, this was the first study using a multivariate approach –
both for genetic and imaging data – to investigate associations between
brain grey matter and polygenic risk scores for four psychiatric ill-
nesses. We show that both the autism and the schizophrenia risk scores
are significantly predicted by grey matter structure. These results sup-
port the hypothesis that cumulative genetic risk for autism and schi-
zophrenia is associated with changes in grey matter concentrations
across the brain. Autism develops early in life and is associated with
severe neurodevelopmental symptoms, including brain structural
changes. This is likely contributing to our current findings, suggesting
genetic risk for autism might be associated with relatively large changes
in brain structure even in individuals not expressing the illness. That
the pattern of associations was widespread across the brain, as
Fig. 2. Results for the schizophrenia polygenic risk score (PRS). A) Correlations between actual schizophrenia PRS and the PRS predicted from grey matter
volume maps. pFDR= False Discover Rate corrected p-values. B) Weight maps of contribution of voxels across the whole brain for the predicted schizophrenia PRS
shown in A (in the whole sample, N= 213).
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expected, supports the use of a multivariate approach to detect these
patterns of changes in grey matter.
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